Results 211 to 220 of about 5,080,573 (227)

Observation as the initial management strategy in patients with mantle cell lymphoma

Annals of Oncology, 2017
Randy Gascoyne, Diego Villa, K J Savage   +2 more
exaly  

Central nervous system involvement in mantle cell lymphoma

Annals of Oncology, 2008
Francesc Bosch, A López-Guillermo
exaly  

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Annals of Oncology, 2013
Marco Ladetto, Luca Arcaini
exaly  

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

Annals of Oncology, 2013
Pier Luigi Zinzani, J Polikoff, P L Zinzani   +2 more
exaly  

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of Oncology, 2015
Dai Chihara, John Seymour, R E Champlin   +2 more
exaly  

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Annals of Oncology, 2009
Benjamin Djulbegovic, E Epner, J P Leonard   +2 more
exaly  

Management of mantle cell lymphoma

Annals of Hematology, 1999
P, Meusers, J, Hense
openaire   +2 more sources

Hematopoietic stem cell transplantation in mantle cell lymphoma

Annals of Oncology, 2005
Julie Vose, Apar Kishor Ganti, Philip J Bierman   +2 more
exaly  

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)

Annals of Oncology, 2017
R T Hoppe, A K Ng, R W Tsang
exaly  

Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma

Annals of Oncology, 2014
Y L Kwong, H Gill
exaly